Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia

Cytometry Part B - Clinical Cytometry

Volumn 70, Issue 3, 2006, Pages 124-135

  Habib, Luzette K ^a   Finn, William G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chronic lymphocytic leukemia; Class discovery; Cluster analysis; Flow cytometry

Indexed keywords

CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER CLASSIFICATION; CHRONIC LYMPHATIC LEUKEMIA; CLUSTER ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

AGED; ANTIGENS, CD20; ANTIGENS, CD22; ANTIGENS, CD38; BONE MARROW CELLS; CLUSTER ANALYSIS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTES; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; PROTEOMICS; RECEPTORS, IGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646508362     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20091     Document Type: Article

References (18)

1. Sellers TA, Yates JR. Review of proteomics with applications to genetic epidemiology. Genet Epidemiol 2003;24:83-98.
2. Tyers M, Mann M. From genomics to proteomics. Nature 2003;422:193-197.
3. Hanash S. Disease proteomics. Nature 2003;422:226-232.
4. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003;3:267-275.
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
6. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Jr., Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
7. Alaiya AA, Franzen B, Hagman A, Dysvik B, Roblick UJ, Becker S, Moberger B, Auer G, Linder S. Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int J Cancer 2002;98:895-899.
8. Dwek MV, Alaiya AA. Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues. Br J Cancer 2003;89:305-307.
9. Maynadie M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G, Campos L, Dromelet A, Lepelley P, Jouault H, Imbert M, Rosenwadj M, Verge V, Bissieres P, Raphael M, Bene MC, Feuillard J; Groupe d'Etude Immunologique des Leucemies (GEIL). Immunophenotypic clustering of myelodysplastic syndromes. Blood 2002;100:2349-2356.
10. Hulkkonen J, Vilpo L, Hurme M, Vilpo J. Surface antigen expression in chronic lymphocytic leukemia: Clustering analysis, interrelationships and effects of chromosomal abnormalities. Leukemia 2002;16:178-185.
11. Hair JF, Black WC. Cluster analysis. In: Grimm LG, Yarnold PR, editors. Reading and Understanding More Multivariate Statistics. Washington, DC: American Psychological Association; 2000. p 147-205.
12. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868.
13. Jelinek DF, Tschumper RC, Stolovitzky GA, Iturria SJ, Tu Y, Lepre J, Shah N, Kay NE. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res 2003;1:346-361.
14. Edwards JC, Cambridge G. Prospects for B-cell-targeted therapy in autoimmune disease. Rheumatology 2005;44:151-156.
15. Mainou-Fowler T, Dignum HM, Proctor SJ, Summerfield GP. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL). Leuk Lymphoma 2004;45:455-462.
16. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98:181-186.
17. Serke S, Schwaner I, Yordanova M, Szczepek A, Huhn D. Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: Evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry 2001; 46:98-104.
18. Polyak MJ, Ayer LM, Szczepek AJ, Deans JP. A cholesterol-dependent CD20 epitope detected by the FMC7 antibody. Leukemia 2003;17:1384-1389.